Product Information
CALCITRIOL 0.5 MCG CAPSULE is a generic product labeled by Strides Pharma Inc., priced at $0.2340 per EA under NDC 64380072406. Its NADAC has been published 610 times since Jan 28, 2015.
FDA first approved this application on Dec 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 ug/1
Manufacturer
Strides Pharma Inc.NDC
64380072406
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CALCITRIOLApproval Type
Generic (ANDA)
FDA Application
ANDA091356FDA Approved
12/12/2014
TE Code
AB
On Market Since
12/27/2016
Pharmacological Classes
Price Statistics
The NADAC for CALCITRIOL 0.5 MCG CAPSULE has been published 610 times since Jan 28, 2015, and over the history we have for it it has declined 72.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2340 per EA |
|---|---|
| All-time high | $0.8517 (Mar 11, 2015) |
| All-time low | $0.1796 (Apr 17, 2024) |
| 52-week high | $0.2516 |
| 52-week low | $0.2340 |
| Median price | $0.3318 |
| Average price | $0.4125 |
| Largest weekly change | -36.4% (Apr 17, 2024) |
| Weeks tracked | 610 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Calcitriol Capsules 0.5 mcg market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcitriol Capsules 0.5 mcg market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin D3 Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CALCITRIOL 0.5 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CALCITRIOL 0.5 MCG CAPSULE, manufactured by Strides Pharma Inc., is $0.2340 per EA (NDC 64380072406), effective Sep 30, 2026.
How has the price of CALCITRIOL 0.5 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for CALCITRIOL 0.5 MCG CAPSULE has declined 72.4%. It has been tracked across 610 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for CALCITRIOL 0.5 MCG CAPSULE?
Since Jan 28, 2015, the NADAC for CALCITRIOL 0.5 MCG CAPSULE has ranged from a low of $0.1796 (Apr 17, 2024) to a high of $0.8517 (Mar 11, 2015), with a median of $0.3318 per EA.
Are there cheaper alternatives to CALCITRIOL 0.5 MCG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of CALCITRIOL 0.5 MCG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CALCITRIOL 0.5 MCG CAPSULE?
CALCITRIOL 0.5 MCG CAPSULE (NDC 64380072406) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.